Kangmei Pharmaceutical Co Ltd (600518) — Long-term Investment Intensity
Kangmei Pharmaceutical Co Ltd (600518) has a Long-term Investment Intensity of 0.9% as of September 2019. Long-term investments of CN¥640.63 Million represent 0.9% of total assets of CN¥71.78 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Kangmei Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kangmei Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Kangmei Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 0.9%, reflecting long-term investments of CN¥640.63 Million against total assets of CN¥71.78 Billion CNY. Explore 600518 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Kangmei Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Kangmei Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600518 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.8% | CN¥556.58 Million | CN¥73.14 Billion | ▼ -0.1 pp |
| 2017 | 0.8% | CN¥543.60 Million | CN¥65.29 Billion | ▼ 0.0 pp |
| 2016 | 0.9% | CN¥474.62 Million | CN¥54.82 Billion | ▼ -0.3 pp |
| 2015 | 1.1% | CN¥437.00 Million | CN¥38.11 Billion | — |